Turbine Truck Engines, Inc. Closes Novo Healthnet Limited Acquisition
May 10, 2017 12:02 pm UTC| Business
BELLEVUE, Wash., May 10, 2017 -- Turbine Truck Engines, Inc. (OTCQB:TTEG)(“TTE”) is pleased to announce the closing of a share exchange with the Novo Healthnet Limited (“Novo”) shareholders, pursuant to which TTE has...
Turbine Truck Engines, Inc. Closes Novo Healthnet Limited Acquisition
May 10, 2017 12:02 pm UTC| Business
BELLEVUE, Wash., May 10, 2017 -- Turbine Truck Engines, Inc. (OTCQB:TTEG)(“TTE”) is pleased to announce the closing of a share exchange with the Novo Healthnet Limited (“Novo”) shareholders, pursuant to which TTE has...
Independent Study Reveals the Critical Need for Real-Time Customer Experience Data Platforms
May 10, 2017 12:02 pm UTC| Business
95% of organizations are currently unable to make sense of customer data and struggle to gain real-time insights from this dataAlmost 90% of organizations believe they would see notable improvements in their CX as a result...
May 10, 2017 12:02 pm UTC| Business
ITASCA, Ill., May 10, 2017 -- Flexera, the company that’s reimagining the way software is bought, sold, managed and secured, announced today it’s reimagining software supply chain safety. Flexera’s the first-in-industry...
CommerceHub Announces Schedule of Upcoming Investor Conferences
May 10, 2017 12:02 pm UTC| Business
ALBANY, N.Y., May 10, 2017 -- CommerceHub, Inc. (NASDAQ:CHUBA) (NASDAQ:CHUBK) (“CommerceHub” or the “Company”), a leading distributed commerce network for retailers and brands, today announced that management will...
May 10, 2017 12:02 pm UTC| Business
ITASCA, Ill., May 10, 2017 -- Flexera, the company that’s reimagining the way software is bought, sold, managed and secured, announced today it’s reimagining software supply chain safety. Flexera’s the first-in-industry...
Proteon Therapeutics Announces First Quarter 2017 Financial Results
May 10, 2017 12:01 pm UTC| Business
WALTHAM, Mass., May 10, 2017 -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, today...